A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy

NCT06510114 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Graves Ophthalmopathy

Interventions

DRUG: methylprednisolone(daily scheme)
DRUG: methylprednisolone(weekly scheme)

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University